Provided by Tiger Trade Technology Pte. Ltd.

Lumos Pharma Inc.

4.34
0.0000
Volume:- -
Turnover:2.09M
Market Cap:37.54M
PE:-1.01
High:4.34
Open:4.34
Low:4.34
Close:4.34
52wk High:4.58
52wk Low:1.37
Shares:8.65M
Float Shares:5.84M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.2798
EPS(LYR):-4.1784
ROE:-172.83%
ROA:-69.64%
PB:7.64
PE(LYR):-1.04

Loading ...

Company Profile

Company Name:
Lumos Pharma Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of products and therapies for people with rare diseases. Its primary product candidate is LUM-201, an oral growth hormone secretagogue ibutamoren, which is in Phase III clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company has a clinical collaboration with Massachusetts General Hospital to evaluate oral LUM-201 in nonalcoholic fatty liver disease. Lumos Pharma, Inc. is headquartered in Austin, Texas.